NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has licensed technology to Hologic after the firms settled over a patent dispute.
Hologic was one of 10 companies that Genetic Technologies sued in May for alleged infringement of US Patent 5,612,179, titled "Intron Sequence Analysis Method for Detection of Adjacent Locus Alleles as Haplotypes." The patent relates to methods of analyzing non-coding DNA sequences.
The other defendants named in the suit were Agilent Technologies, Bristol-Myers Squibb, Eurofins STA Laboratories, GlaxoSmithKline, Merial, Navigenics, Neogen, Pfizer, and Roche's 454 Life Sciences.
Hologic is the second firm to settle with the Australian firm after Navigenics settled in June. Genetic Technologies issued the direct-to-consumer genetic firm a license for use of the technology.
Terms of the licensing deal with Hologic were not disclosed.
In April, Genetic Technologies concluded a lawsuit filed in early 2010 against several companies also for alleged infringement of the '179 patent.